May 20 (Reuters) - Regeneron Pharmaceuticals Inc REGN.O:
VIZ.AI ANNOUNCES COLLABORATION WITH SANOFI AND REGENERON TO IMPROVE MANAGEMENT AND CARE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
VIZ.AI: WITH SUPPORT FROM SANOFI & REGENERON, VIZ.AI WILL INVESTIGATE USE OF VIZ COPD MODULE
Source text: ID:nBw4S1MMKa
Further company coverage: REGN.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.